Low-dose, once-daily, intraclot injections of alteplase for treatment of acute deep venous thrombosis

Journal of Vascular and Interventional Radiology

Volumn 22, Issue 8, 2011, Pages 1107-1116

  Chang, Richard ^a   Horne III, McDonald K ^a   Shawker, Thomas H ^a   Kam, Anthony W ^b   Chen, Enn Alexandria ^c   Joe, Galen O ^d   Ching, Willie L ^d   Mao, Edie ^a   Wyrick Jr , David A ^a   Lozier, Jay N ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b JOHNS HOPKINS BAYVIEW MEDICAL CENTER   (United States)

^c Excela Health Westmoreland Hospital   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; ARGATROBAN; ENOXAPARIN; F PENTAS; HEPARIN; PENTASACCHARIDE; UNCLASSIFIED DRUG; WARFARIN;

ADOLESCENT; ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; BARE METAL STENT; BED REST; BLEEDING; CATHETER THROMBOSIS; CENTRAL VEIN; CONTINUOUS INFUSION; DEEP VEIN THROMBOSIS; DISEASE DURATION; DISEASE SEVERITY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG SAFETY; FEMALE; FIBRINOLYTIC THERAPY; FOLLOW UP; HEMATOMA; HUMAN; INTERNATIONAL NORMALIZED RATIO; JUGULAR VEIN; LEG EDEMA; LEG PAIN; LEG THROMBOSIS; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MAY THURNER SYNDROME; OUTPATIENT CARE; PARTIAL THROMBOPLASTIN TIME; POSTTHROMBOSIS SYNDROME; PRIORITY JOURNAL; PROSPECTIVE STUDY; STENOTROPHOMONAS MALTOPHILIA; SUBCLAVIAN JUGULAR AND CENTRAL VEIN THROMBOSIS; TREATMENT DURATION; TREATMENT OUTCOME; VASCULAR PATENCY; VEIN OCCLUSION;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME; VASCULAR PATENCY; VENOUS THROMBOSIS;

EID: 79960926455     PISSN: 10510443     EISSN: 15357732     Source Type: Journal    
DOI: 10.1016/j.jvir.2011.03.023     Document Type: Article

References (25)

1. R. Watz, and G.F. Savidge Rapid thrombolysis and preservation of venous function in high deep vein thrombosis Acta Med Scand 205 1979 203 298
2. M.H. Meissner, R.A. Manzo, R.O. Bergelin, A. Markel, and D.E. Strandness Deep venous insufficiency: the relationship between lysis and subsequent reflux J Vasc Surg 18 1993 596 608 (Pubitemid 23314140)
3. J.M. Rhodes, J.S. Cho, P. Gloviczki, G. Mozes, R. Rolle, and V.M. Miller Thrombolysis for experimental deep venous thrombosis maintains valvular competence and vasoreactivity J Vasc Surg 31 2000 1193 1205 (Pubitemid 30418491)
4. M.W. Mewissen, G.R. Seabrook, and M. Meissner Catheter-directed thrombolysis for lower extremity deep vein thrombosis: report of a national multicenter registry Radiology 211 1999 39 49 (Pubitemid 29161732)
5. C. Semba, and M.D. Dake Iliofemoral deep venous thrombosis: aggressive therapy with catheter-directed thrombolysis Radiology 191 1994 487 494
6. H. Bjarnason, J.R. Kruse, and D.A. Asinger Iliofemoral deep venous thrombosis: safety and efficacy outcome during 5 years of catheter-directed thrombolytic therapy J Vasc Interv Radiol 8 1997 405 418 (Pubitemid 27524134)
7. H. Sillesen, S. Just, M. Jorgensen, and N. Baekgaard Catheter directed thrombolysis for treatment of ilio-femoral deep venous thrombosis is durable, preserves venous valve function and may prevent chronic venous insufficiency Eur J Vasc Endovasc Surg 30 2005 556 562 (Pubitemid 41472430)
8. M.R. Grunwald, and L.V. Hoffman Comparison of urokinase, alteplase, and reteplase for catheter-directed thrombolysis of deep vein thrombosis J Vasc Interv Radiol 15 2004 347 352 (Pubitemid 38451977)
9. K. Ouriel, B. Gray, D.G. Clair, and J. Olin Complications associated with the use of urokinase and recombinant tissue plasminogen activator for catheter-directed peripheral arterial and venous thrombolysis J Vasc Interv Radiol 11 2000 295 298 (Pubitemid 30161372)
10. S.Z. Goldhaber, M.F. Meyerovitz, and D. Green Randomized controlled trial of tissue plasminogen activator in proximal venous thrombosis Am J Med 88 1990 235 240 (Pubitemid 20100369)
11. N. Baekgaard, R. Broholm, S. Just, M. Jorgensen, and L.P. Jensen Long-term results using catheter-directed thrombolysis in 103 lower limbs with acute iliofemoral venous thrombosis Eur J Vasc Endovasc Surg 39 2010 112 117
12. C.P. Semba, C. Bakal, and K.A. Calis Alteplase as an alternative to urokinase J Vasc Interv Radiol 11 2000 279 287 (Pubitemid 30161370)
13. V.J. Marder, B. Brenner, and S. Totterman Comparison of dosage schedules of rt-PA in the treatment of proximal deep vein thrombosis J Lab Clin Med 119 1992 485 495
14. R. Chang, M.K. Horne III, D.J. Mayo, and J.L. Doppman Pulse-spray treatment of subclavian and jugular venous thrombi with recombinant tissue plasminogen activator J Vasc Interv Radiol 7 1996 845 851 (Pubitemid 126729609)
15. R. Chang, C. Chen, A. Kam, E. Mao, T. Shawker, and M.K. Horne III Deep vein thrombosis of the lower extremity: direct intraclot injection of alteplase once daily with systemic anticoagulation: results of a pilot study Radiology 246 2008 619 629
16. M.K. Horne III, and R. Chang Pharmacokinetics of pulse-sprayed recombinant tissue plasminogen activator for deep vein thrombosis Thromb Res 111 2003 111 114 (Pubitemid 37485934)
17. R. Chang, R.O. Cannon III, and C.C. Chen Daily catheter-directed single dosing of t-PA in treatment of acute deep venous thrombosis of the lower extremity J Vasc Interv Radiol 12 2001 247 252 (Pubitemid 32167788)
18. V.J. Marder, R.L. Soulen, and V. Atichartakarn Quantitative venographic assessment of deep vein thrombosis in the evaluation of streptokinase and heparin therapy J Lab Clin Med 89 1977 1018 1029 (Pubitemid 8107518)
19. C.T. Dotter, J. Rosch, and A.J. Seaman Selective clot lysis with low-dose streptokinase Radiology 111 1974 31 37
20. G. Agnelli, M.R. Buchanan, F. Fernandez, J. Van Ryn, and J. Hirsh Sustained thrombolysis with DNA recombinant type tissue plasminogen activator in rabbits Blood 66 1985 399 401 (Pubitemid 15007032)
21. G. Agnelli Rationale for bolus t-PA therapy to improve efficacy and safety Chest 97 4 Suppl 1990 161S 167S (Pubitemid 20119569)
22. A. Ahmed, W.B. Shapiro, and J.G. Porush The use of tissue plasminogen activator to declot arteriovenous access in hemodialysis patients Am J Kidney Dis 21 1993 38 43 (Pubitemid 23062770)
23. D. Vlassopoulos, E. Logothetis, and C. Arvanitis Local thrombolysis with recombinant tissue plasminogen activator for thrombosed vascular access in hemodialysis patients (letter to editor) Clin Nephrol 46 1996 77 78
24. Y. Boobes, H.A. Hassan, P. Neglen, K. Obeid, and N. Denour Recombinant tissue plasminogen activator to declot dialysis fistulas J Nephrol 10 1997 107 110 (Pubitemid 27238903)
25. A. Falk, H. Mitty, J. Guller, V. Teodorescu, J. Uribarri, and J. Vassalotti Thrombolysis of clotted hemodialysis grafts with tissue plasminogen activator J Vasc Interv Radiol 12 2001 305 311 (Pubitemid 32217027)